Pharmacuetical companies accused of refusing to invest in a cure

An Irish mum whose son suffers from a rare genetic disorder has accused pharmaceutical companies of refusing to invest in a cure.

Pharmacuetical companies accused of refusing to invest in a cure

An Irish mum whose son suffers from a rare genetic disorder has accused pharmaceutical companies of refusing to invest in a cure.

One-year-old Hagan Kavanagh has cystinosis which over time will crystallise his cells and destroy his organs.

You have reached your article limit. Already a subscriber? Sign in

Save €40 on an Annual Subscription.​

Continue reading within unlimited digital access and exclusive subscriber benefits.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited